Oral erythromycin for the prevention and treatment of feeding intolerance in preterm infants-meta analysis of randomized controlled trials

( views:439, downloads:0 )
ZHANG Zhi-qun(Department of Pediatrics,Hangzhou Hospital Affiliated to Nanjing Medical University,Hangzhou 310006,China)
LI Hui-ping()
HUANG Xian-mei(Department of Pediatrics,Hangzhou Hospital Affiliated to Nanjing Medical University,Hangzhou 310006,China)
ZHU Jian-xing()
Journal Title:
Volume 13, Issue 03, 2010
Key Word:
Infant,premature;Erythromycin;Parenteral nutrition,total;Meta-analysis

Abstract: Objective To evaluate the efficacy and safety of oral erythromycin in the prevention and treatment of feeding intolerance in preterm infants. Methods The Cochrane Library,PubMed,EMBASE,CBMdise,VIP,WartFang and CNKl were searched up to the year of 2008.Randomized controlled trials (RCT) of erythmmycin for feeding intolerance in preterm infants were included.According to the dosage (low-dose,3-15 mg/kg and high dose,>15 mg/kg)and gestational age(≤32 weeks vs>32 weeks),all infants were divided into several subgroups.Meta-analysis was performed with the Cochrane Collaboration's software RevMan. Results Nine RCrs involving 542 premature infants were included.(1)In preventive studies,low-dose erythromycin could significantly decrease the duration of total parenteral nutrition compared with the high-dose erythmmycin (WMD=-2.99,95%CI:-3.99--1.98).(2)Intreatment studies,highdose erythromycin could significantly decrease the duration of total parenteral nutrition (WMD=-7.06.95%CI:-7.91--6.20,P<0.01)and hospital stay (WMD=-8.10,95%CI:-14.02--2.18,P=0.007)compared with the placebo when gestational age≤32 weeks. Erythromydn could decrease the incidence of iaundice(RR=0.36,95%CI:0.21-0.63,P=0.0003)which might be the effect of bigh-dose erytromycin. Conclusions Compared with placebo,oral erythromycin of different dosage might help to achieve full enteral feeding,shorten the duration of parenteral nutrition and hospital stay,and reduce the associated cholestasis jaundice of preterm infants with different gestational age respectively.

  • [1]Berseth CL.Gastrointestinal motility in the neonate.Clin Perinatol,1996,23:179-190.
  • [2]Morris BH,Miller-Loncar CL,Landry SH,et al.Feeding,medical factors,and developmental outcome in premature infants.Clin Pediatr,1999:38:451-457.
  • [3]Peeters T,Matthijs G,Depoortere I,et al.Erythromycin is a motilin receptor agonist.Am J Physiol,1989,257:G470-G474.
  • [4]Ng SC,Gomez JM,Rajadurai VS,et al.Establishing enteral feeding in preterm infants with feeding intolerance;a randomized controlled study of low-dose erythromyein.J Pediatr GaatroenteroI Nutr,2003,37:554-558.
  • [5]Costalos C,Gounaris A,Varhalama,et al.Erythromycin as a prokinetic agent preterm infants.J Pediatr Gastroenterol Nutr,2002,34:23-25.
  • [6]Ng E,Shah VS.Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.Cochrane Database Syst Rev,2008,(16):CD001815.
  • [7]Patole SK,Rap S,Doherty D.Erythromyein as a prokinetie agent in preterm neonates:a systematic review.Arch Dis Child Fetal Neonatal Ed,2005,90:301-306.
  • [8]张志群,李惠萍,朱建幸.静脉小剂量红霉素防治早产儿喂养不耐受的meta分析,中国循证儿科杂志,2009,4:280-288.
  • [9]Kuzma-O'Reilly B,Duenas ML,Greecher C,et al.Evaluation,development,and implementation of potentially better practices in neonatal intensive care nutrition.Pediatrics,2003,111:e461-e470.
  • [10]Higgins JPT,Green s.Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 7[updated Dec 2008].The Cochrane Collaboration,2008.Available from www.cochrane-handbook.org.
  • [11]Patole SK.Almonte R,Kadalraja R,et al.Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?Int J Clin Pract,2000,54:504-508.
  • [12]Oei J,Lui K.A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.Acts Paediatr,2001,90:904-908.
  • [13]王卫,刘晓红,李安琪,等.小剂量红霉素对胃食管返流和24小时胃食管pH值的研究.中华围产医学杂志,2005,8:413-414.
  • [14]Ng PC,Lee CH,Wong SP,et al.High-dose oral erythromycin decreased the incidence of parenteral nutritionassociated cholestasis in preterm infants.Gastroenterology,2007,132:1726-1739.
  • [15]Madani A,Pishva N,Pourarian Sh,et al.The efficacy of oral erythromycin in enhancement of milk tolerance in premature infants:A randomized controlled trial.Iranian J Med Sciences,2004,29:1-4.
  • [16]Nunmarumit P,Kiatchoosakun P,Tantiprapa W,et al.Efficacy of oral erythromycin for treatment of feeding intolerance in preterm intants.J Pediatr,2006,148:600-605.
  • [17]ElHennawy AA,Sparks JW,Armentrout D,et al.Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.J Pediatr Gastroenterol Nutr,2003,37:281-286.
  • [18]Aly H,Abdel-Hady H,Khashaba M,et al.Erythromycin and feeding intolerance in premature infants:a randomized trial.J Perinatol.2007,27:39-43.
  • [19]Jadcherla SR,Klee G,Berseth CL.Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants.Pediatr Res,1997,42:365-369.
  • [20]Mathis C,Malbert CH.Changes in pylorie resistance induced by erythromydn.Neurngastroenterol Motil,1998,10:131-138.
  • [21]Coulie B,Tack J,Peeters T,et al.Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans.Gut,1998,43:395-400.
  • [22]Bruley des Varannes S,Parys V,Ropert A,et al.Erythromycin enhances fasting and postprandial proximal gastric tone in humans.Gastroenterology,1995,109:32-39.
  • [23]Tack J,Janssens J,Vantrappen G,et al.Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.Gastroenterology,1992,103:72-79.
  • [24]Fraser R,Shearer T,Fuller J,et al.Intravenous erythromycin overcomes small intestinal feedback on antral.pyloric,and duodehal motility.Gastroenterology,1992,103:114-119.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn